Understanding the Reasons and Issues for Low NMOSD Activity Rates: Farrah Mateen, MD, PhD

Published Date: 02 Mar 2023

Understanding the Reasons and Issues for Low NMOSD Activity Rates: Farrah Mateen, MD, PhD

Read Full News

Latest News

FDA Neurology Roundup: April 2026

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

Migraine Tied to Lower Dementia, Alzheimer’s Risk

Migraine is linked to a 30% lower risk for dementia and a 42% lower risk for Alzheimer’s disease than not having migraine, a new cohort study shows.

Certain Multiple Sclerosis Drugs Tied to Lower Uveitis Risk

The use of nucleic acid synthesis inhibitors or sphingosine-1-phosphate modulators, fumarates, or interferons is linked to a lower risk for noninfectious uveitis in patients with MS, a new study finds.

HHS Pushes to Stop ‘Overprescribing’ of Psychiatric Meds

A new HHS action plan aims to curb psychiatric drug “overprescribing” and expand nonmedication mental health care, drawing criticism from the APA.

When Retirement Triggers Risk: Substance Use in Older Adults

Retirement's a critical window: Boredom, pain, and social withdrawal can push older patients toward alcohol or drugs. Doctors should screen, counsel, and refer to tailored services.

Personalized Stimulation Boosts Outcomes in Essential Tremor

Customizable waveforms in a wearable stimulation device were associated with higher responder rates than standard settings in new research.

Todays Updates

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

GuCS: Genitourinary Cancers Symposium

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Todays Updates

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

GuCS: Genitourinary Cancers Symposium

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Latest News

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

Migraine is linked to a 30% lower risk for dementia and a 42% lower risk for Alzheimer’s disease than not having migraine, a new cohort study shows.

The use of nucleic acid synthesis inhibitors or sphingosine-1-phosphate modulators, fumarates, or interferons is linked to a lower risk for noninfectious uveitis in patients with MS, a new study finds.

A new HHS action plan aims to curb psychiatric drug “overprescribing” and expand nonmedication mental health care, drawing criticism from the APA.

Retirement's a critical window: Boredom, pain, and social withdrawal can push older patients toward alcohol or drugs. Doctors should screen, counsel, and refer to tailored services.

Customizable waveforms in a wearable stimulation device were associated with higher responder rates than standard settings in new research.

News All Time

Common Genetic Cause of Intellectual Disability Identified

A newly identified recessive neurodevelopmental disorder may be among the most common genetic causes of intellectual disability and epilepsy, new research suggests.

Roche: New Elevidys Study After Feedback From EU Regulator

Roche said it is initiating a late stage study for its ⁠gene therapy Elevidys following feedback from the European drug regulator.

New Evidence Strengthens the Case for Iatrogenic Alzheimer’s

Researchers report the first autopsy-confirmed case of Alzheimer's disease following suspected medical transmission, but experts say definitive causation may remain elusive.

Experts Push Back on WHO’s ‘Misleading’ Portrayal of ECT

Leading psychiatry groups say WHO guidance on ECT risks stigmatizing and reducing access to a safe, effective, and sometimes life-saving treatment for patients with severe mental illness.

Do Early Birds Have a Lower Risk for ALS?

Earlier bedtime and wake time and regular physical activity are associated with a significant reduction in ALS risk, a new study shows.

Halting MOGAD Treatment Tied to Lower Relapse Risk

Stopping treatment for myelin oligodendrocyte glycoprotein antibody-associated disease is linked to fewer relapses than treatment continuation, new research shows.

FDA OKs Drug to Treat Neurologic Symptoms in Hunter Syndrome

The U.S. Food and Drug Administration has approved Denali Therapeutics' therapy to treat children ⁠with a rare genetic disorder, marking the first regulatory green light for...

FDA Seeks New Warning for Certain Parkinson's Drugs

The FDA said on Friday it has notified manufacturers of certain Parkinson's ⁠disease treatments to update their prescribing information with a...

Scottish Lawmakers Vote Against Allowing Assisted Dying

Scottish lawmakers have voted against legalising assisted, crushing hopes for a historic law change, ⁠as similar proposals in England and Wales also look set to fail.

Little Evidence of Cannabis Efficacy for Psychiatric Illness

A new review shows insufficient or low-quality evidence to suggest cannabinoids are effective at treating most psychiatric conditions and substance use disorders.

Prenatal Antiseizure Med Exposure: Risks Vary by Agent

A large cohort study sheds new light on neurodevelopmental risk in children after prenatal antiseizure medication exposure, with variation across individual agents.

Anxiety and Depression May Raise Risk for Aneurysm Rupture

Anxiety and depression are linked to an increased risk for rupture and mortality in patients with unruptured intracranial aneurysms, a new cohort study shows.

China Approves Market Launch Of Brain-computer Interface Medical Device in World First

China's drug regulator said on Friday that it has given the nod for a brain-computer interface (BCI) system ⁠that helps restore hand-movement ability to be sold, the world's...

Why Aren’t Canadians Getting Enough Sleep?

The change to daylight saving time and the marking of World Sleep Day call attention to the factors that contribute to sleep deficits among Canadians.

Single IV Ketamine Promising for Depression in MCI

Ketamine is well-tolerated in older adults with both mild cognitive impairment and depression and associated with improved depression scores, a new study shows.

Late Complications Common After CVT, Even After Recovery

Although a majority of patients with cerebral venous sinus thrombosis achieve independence, 1 in 3 may develop delayed complications such as seizures, a study shows.

Recommended News For You

From Pathology to Precision: The Story of Leukemia Therapy

Increased Exercise May Lower the Risk of Prostate Cancer.

Increased anti-tumor response and reduced side effects from immune checkpoint inhibitors.

Enhanced access for patients with prostate cancer is provided by the new SPECT/CT technique, which demonstrates remarkable biomarker identification.

Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

Triplet Therapy Improves Posttransplant Outcomes in Myeloma

Recommended Articles For You

Expanding Oncology Frontiers: Rare Cancers, Breakthroughs, and Precision Medicine Advances 

Neutrophil Profiling and AI Rewrites Cancer Diagnosis 

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases 

Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

2.

recognizing the mechanism by which the replication of the host cell is outperformed by the skin cancer virus.

3.

Clinical trial is testing whether heavy lifting could combat cancer side effects

4.

By acquiring T3 Pharma, a leader in bacterial cancer treatment, Boehringer Ingelheim broadens its offering in immunooncology.

5.

Dual-action mRNA vaccine takes aim at aggressive skin cancer

1.

Methemoglobinemia in OR & ICU: Pathophysiology, Detection, and Management Review

2.

Exploring the Potential of Xospata: A New Frontier in Cancer Treatment

3.

Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics

4.

The Evolving Arsenal: A 2025 Review of Antibody-Drug Conjugates and the Future of Precision Oncology

5.

Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part XIII

2.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part IV

3.

Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases

4.

An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III

5.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot